Chad McDuffie, MD
Otolaryngology · Frisco, TXNPI 1851341085
Payments from drug & device makers
Across 220 payments — averaging $6623.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$674K
- Sanofi US Services Inc.$424K
- GSK$222K
- Intersect ENT, Inc.$116K
- Medtronic$19K
- Stryker$506
- plus $2K from 16 others
What the payments were for
- Food & beverage$2,930100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 36 | $674,180 |
| Sanofi US Services Inc. | 27 | $424,191 |
| GSK | 71 | $221,550 |
| Intersect ENT, Inc. | 8 | $115,726 |
| Medtronic | 11 | $19,360 |
| Stryker | 14 | $506 |
| Acclarent, Inc | 10 | $436 |
| Inspire Medical Systems, Inc. | 8 | $399 |
| Sanofi | 8 | $202 |
| Integra Lifesciences Corporation | 5 | $167 |
| Regeneron Healthcare Solutions, Inc. | 5 | $106 |
| Neurent Medical Limited | 2 | $75 |
| Optinose US, Inc. | 3 | $49 |
| Smith+Nephew | 2 | $48 |
| AstraZeneca | 2 | $41 |
| Merck | 2 | $38 |
| ZOLL Respicardia, Inc. | 1 | $30 |
| Kerecis Limited | 1 | $21 |
| Alk-abello, Inc | 1 | $19 |
| Kaleo, Inc. | 1 | $18 |
| Glenmark Therapeutics Inc. | 1 | $14 |
| Aytu Biopharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$269
How this compares
$1,457,190 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 179 | $4,414 |
| CefuroximeCefuroxime Axetil | 95 | $1,822 |
| Ofloxacin | 35 | $973 |
| Omeprazole | 86 | $892 |
| Fluocinolone Acetonide Oil | 17 | $845 |
| Levothyroxine Sodium | 53 | $386 |
| Methylprednisolone | 49 | $343 |
| Fluticasone Propionate | 33 | $319 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 34 | $289 |
| Azelastine Hcl | 11 | $271 |
| Montelukast Sodium | 19 | $201 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $157 |
| Clindamycin Hcl | 15 | $141 |
| Amoxicillin | 42 | $107 |
| Ondansetron OdtOndansetron | 21 | $89 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Frisco
- Dale EhmerFrisco$362K
- Keith MathenyFrisco$281K
- Neelesh MehendaleFrisco$188K
- Lav KapadiaFrisco$154K
- Laurence ChuAustin$37.4M
- Mark ZafereoHouston$7.8M
- Neil GrossHouston$1.5M
- Ian AlexanderBoerne$999K
- Stephen LaiHouston$968K
- Benjamin CilentoSpring$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.